Factors affecting the Turnaround Time for Manufacturing, Testing and Release of Cellular Therapy Products prepared at Multiple Sites in support of Multicenter Cardiovascular Regenerative Medicine Protocols – a Cardiovascular Cell Therapy Research Network (CCTRN) Study

BACKGROUND: Cellular therapy studies are often conducted at multiple clinical sites in order to accrue larger patient numbers. In many cases this necessitates use of localized Good Manufacturing Practices (GMP) facilities to supply the cells. To assure consistent quality, oversight by a quality assu...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Richman, Sara, Gee, Adrian P., McKenna, David, Traverse, Jay, Henry, Timothy, Fisk, Diann, Pepine, Carl, Bloom, Jeannette, Willerson, James, Prater, Karen, Zhao, David, Koç, Jane Reese, Anwaruddian, Saif, Taylor, Doris, Cogle, Christopher, Moyé, Lemuel, Simari, Robert, Skarlatos, Sonia
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2012
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3355200/
https://ncbi.nlm.nih.gov/pubmed/22320233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1537-2995.2011.03543.x
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg